Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Antimicrob Chemother ; 76(3): 775-783, 2021 02 11.
Artículo en Inglés | MEDLINE | ID: mdl-33249436

RESUMEN

BACKGROUND: Infections caused by KPC-producing Klebsiella pneumoniae (Kp) are associated with high mortality. Therefore, new treatment options are urgently required. OBJECTIVES: To assess the outcomes and predictors of mortality in patients with KPC- or OXA-48-Kp infections treated with ceftazidime/avibactam with an emphasis on KPC-Kp bloodstream infections (BSIs). METHODS: A multicentre prospective observational study was conducted between January 2018 and March 2019. Patients with KPC- or OXA-48-Kp infections treated with ceftazidime/avibactam were included in the analysis. The subgroup of patients with KPC-Kp BSIs treated with ceftazidime/avibactam was matched by propensity score with a cohort of patients whose KPC-Kp BSIs had been treated with agents other than ceftazidime/avibactam with in vitro activity. RESULTS: One hundred and forty-seven patients were identified; 140 were infected with KPC producers and 7 with OXA-48 producers. For targeted therapy, 68 (46.3%) patients received monotherapy with ceftazidime/avibactam and 79 (53.7%) patients received ceftazidime/avibactam in combination with at least another active agent. The 14 and 28 day mortality rates were 9% and 20%, respectively. The 28 day mortality among the 71 patients with KPC-Kp BSIs treated with ceftazidime/avibactam was significantly lower than that observed in the 71 matched patients, whose KPC-Kp BSIs had been treated with agents other than ceftazidime/avibactam (18.3% versus 40.8%; P = 0.005). In the Cox proportional hazards model, ultimately fatal disease, rapidly fatal disease and Charlson comorbidity index ≥2 were independent predictors of death, whereas treatment with ceftazidime/avibactam-containing regimens was the only independent predictor of survival. CONCLUSIONS: Ceftazidime/avibactam appears to be an effective treatment against serious infections caused by KPC-Kp.


Asunto(s)
Antibacterianos , Compuestos de Azabiciclo , Ceftazidima , Infecciones por Klebsiella , Klebsiella pneumoniae , Antibacterianos/uso terapéutico , Compuestos de Azabiciclo/uso terapéutico , Proteínas Bacterianas , Ceftazidima/uso terapéutico , Combinación de Medicamentos , Humanos , Infecciones por Klebsiella/tratamiento farmacológico , Infecciones por Klebsiella/mortalidad , Pruebas de Sensibilidad Microbiana , Sistema de Registros , beta-Lactamasas
2.
Clin Nephrol ; 70(3): 210-9, 2008 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-18793562

RESUMEN

BACKGROUND: Arterial baroreflex sensitivity (BRS) evaluation has been increasingly used as an index of cardiac autonomic control. Cardiac autonomic dysfunction leading to depressed BRS has been associated with an increased risk of ventricular arrhythmias and sudden death in patients with chronic kidney disease (CKD) on hemodialysis (HD). AIM: The purpose of this study was to investigate the effects of an exercise training program during hemodialysis on BRS in CKD patients. PATIENTS AND METHODS: 43 HD patients participated in the study. They were randomly assigned into either a 7-month exercise training program during HD (Group A: n=22 patients) or a sedentary control group (Group B: n=21 patients). Additionally, 20 sex- and age-matched sedentary individuals comprised a healthy control group (Group C). All patients at the beginning and the end of the study underwent a tilt test for evaluation of BRS and an exercise testing with spiroergometric study for cardiorespiratory capacity estimation. The level of Hb, medications and the HD procedure remained stable during the study. RESULTS: At baseline BRS was found to be reduced by 51.5% (p<0.05) and baroreflex effectiveness index (BEI) by 36.4% (p<0.05) in Group A compared with Group C. Initially, all HD patients had also significantly lower exercise time and VO2 peak than the healthy subjects. After training, Group A showed a significant improvement in BRS by 23.0% (p<0.05), in BEI by 27.0% (p<0.05), in event and ramp count by 35.0% (p<0.05) and 29.0% (p<0.05), respectively as well as in VO2 peak by 22.4% (p<0.05) and in exercise time by 40.9% (p<0.05). Significant correlations were found between BRS and METs (r=0.476, p<0.05), BRS and VO2 peak (r=0.443, p<0.05), BEI and METs (r = 0.492, p<0.05), BEI and VO2 peak (r=0.467, p<0.05), event count and VO2 peak (r=0.715, p<0.01), event count and exercise time (r=0.799, p<0.01), in Group A at the end of the study. CONCLUSIONS: Our results indicate that HD patients had considerably reduced cardiorespiratory capacity and impaired cardiac BRS compared to healthy sedentary individuals. Importantly, exercise training during HD yielded a marked increase of the indices representing baroreflex activity in association to the improvement of their functional capacity.


Asunto(s)
Barorreflejo , Ejercicio Físico , Corazón/inervación , Diálisis Renal , Sistema Nervioso Autónomo/fisiopatología , Presión Sanguínea , Prueba de Esfuerzo , Femenino , Frecuencia Cardíaca , Humanos , Masculino , Equivalente Metabólico , Persona de Mediana Edad , Consumo de Oxígeno
4.
Thorax ; 48(11): 1168-9, 1993 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-8296264

RESUMEN

BACKGROUND: The aim of the study was to determine the trend and seasonal variation in hospital admissions for childhood asthma in the Athens region of Greece. METHODS: Data were obtained from hospital registries of the three main children's hospitals in Athens between 1978 and 1988. Children admitted with the diagnosis of asthma, asthmatic bronchitis, or wheezy bronchitis were included. The data were expressed as admission rates per 100,000 of the same aged population. RESULTS: There were 9795 admissions for asthma over the 11 years and the admission rate rose by 294%. Admissions among those aged 0-4 and 5-14 rose by 272% and 379% respectively. Monthly admissions showed a pronounced seasonal variation, rising during the cold damp period in the 0-4 age group, but peaking around May in the 5-14 age group. CONCLUSIONS: These findings suggest that hospital admissions due to asthma in the Athens region have increased considerably since 1978, and that clear cut seasonal variations exist which are specific to age.


Asunto(s)
Asma/epidemiología , Hospitalización/estadística & datos numéricos , Estaciones del Año , Adolescente , Niño , Preescolar , Grecia/epidemiología , Humanos , Lactante , Recién Nacido , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA